Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01574144 · ClinicalTrials.gov registry record
REducing 30-day ADMIssions in posT-discharge Subjects (READMIT)
A clinical trial, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- Completed
- Registry status
- 70
- Enrollment target
NCT01574144 is a clinical trial that has completed, run by Medtronic Cardiac Rhythm and Heart Failure. The registered enrollment target is 70 participants.
The verdict
NCT01574144 has completed, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- COMPLETED
- Registry status
- 70 participants
- Enrollment target
Study Summary
The purpose of this observational study is to collect and characterize multiple physiologic data from a broad subset of subjects with acute heart failure (HF) Changes in physiologic data are expected to correlate with 30-day readmission rates in this population
Interventions
- DEVICE AVIVO™ PiiX Patch Monitor System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2012-04 |
| Est. Completion | 2013-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01574144
The ClinicalTrials.gov registry entry for NCT01574144 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Cardiac Rhythm and Heart Failure, which has 115 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which AVIVO™ PiiX Patch Monitor System is the first listed.
NCT01574144 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01574144 about?
NCT01574144 is a clinical study titled "REducing 30-day ADMIssions in posT-discharge Subjects (READMIT)". The purpose of this observational study is to collect and characterize multiple physiologic data from a broad subset of subjects with acute heart failure (HF) Changes in physiologic data are expected to correlate with 30-day readmission rates in this population
What is the current status of trial NCT01574144?
This trial is currently completed. The enrollment target is 70 participants. The study started on 2012-04. Estimated completion is 2013-08.
What interventions are being tested in trial NCT01574144?
The interventions under investigation include: AVIVO™ PiiX Patch Monitor System (DEVICE).
Who is sponsoring clinical trial NCT01574144?
This trial is sponsored by Medtronic Cardiac Rhythm and Heart Failure, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.